← Leaderboards
Kathleen Mary Buchheit
Brigham And Women'S Hospital
$1,302,645
Attributed
$1,302,645
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $260.4K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,302,645 · 2
By mechanism
K23$1,042,200 · 1
R21$260,445 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Joshua A Boyce$54,050,346
- Nora Amanda Barrett$12,519,597
- Tanya Maria Laidlaw$5,208,119
- Elliot Israel$35,880,602
- Soumya Raychaudhuri$22,210,777
Others in their field
Other Emerging Leaders on “Pathogenesis”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Thomas Denny · Duke University$22,999,550
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$17,335,818
Research focus
PathogenesisQuality Of LifeInflammatoryNoseProductionProteinsCyclooxygenase 1ImpairmentMedicalNew Therapeutic TargetConsumptionPolyposisAspirinDiagnosisAspirin-Exacerbated Respiratory DiseaseChronic RhinosinusitisAsthmaImmunoglobulinsInsightInvestigationMucous MembraneNasal PolypsAffectReaction
Grant awards (7)
Biomarkers predicting nasal polyp recurrence in aspirin-exacerbated respiratory disease$260,445
R21 · FY2025 · AI · contact PI
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease$197,640
K23 · FY2023 · AI · contact PI
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease$197,640
K23 · FY2022 · AI · contact PI
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease$197,640
K23 · FY2021 · AI · contact PI
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease$197,640
K23 · FY2020 · AI · contact PI
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease$54,000
K23 · FY2020 · AI · contact PI
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease$197,640
K23 · FY2019 · AI · contact PI